Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,776
Closed -$341K 272
2025
Q2
$341K Sell
11,776
-848
-7% -$24.1K 0.05% 220
2025
Q1
$362K Sell
12,624
-560
-4% -$21.2K 0.06% 223
2024
Q4
$590K Sell
13,184
-1,282
-9% -$60.5K 0.08% 190
2024
Q3
$639K Sell
14,466
-7,353
-34% -$301K 0.09% 187
2024
Q2
$843K Buy
+21,819
New +$896K 0.12% 161
2023
Q4
Sell
-27,980
Closed -$1.13M 242
2023
Q3
$1.13M Sell
27,980
-558
-2% -$22.1K 0.19% 133
2023
Q2
$1.13M Sell
28,538
-2,229
-7% -$80.7K 0.19% 134
2023
Q1
$1.25M Sell
30,767
-10,816
-26% -$397K 0.22% 136
2022
Q4
$1.38M Sell
41,583
-5,401
-11% -$162K 0.26% 129
2022
Q3
$1.27M Buy
+46,984
New +$1.43M 0.24% 135

Other funds holding DCBO

Stanley-Laman Group's DCBO Position: Q3 2025 in Review

Stanley-Laman Group sold out of Docebo (DCBO) in Q3 2025, closing a stake of 11,776 shares — an estimated $341K sold.

Stanley-Laman Group first reported a position in DCBO in Q3 2022 and held it in 10 quarters. The position peaked at $1.38M in Q4 2022. 89 funds tracked by Wall St. Rank hold DCBO as of Q3 2025.

  • Stanley-Laman Group reported no remaining Docebo position as of Q3 2025 after selling out during the quarter.
  • Stanley-Laman Group sold 11,776 Docebo shares in Q3 2025, an estimated $341K.
  • Stanley-Laman Group first reported a position in Docebo in Q3 2022 and held it in 10 quarters.
  • Stanley-Laman Group's Docebo position peaked at $1.38M in Q4 2022.
  • 89 funds tracked by Wall St. Rank held Docebo as of Q3 2025.

Based on Stanley-Laman Group's 13F filing for Q3 2025, filed 22 Oct 2025.